tyrphostin ag 1024 has been researched along with Lung Neoplasms in 6 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
Lung Neoplasms: Tumors or cancer of the LUNG.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, JH | 1 |
Choi, SI | 1 |
Kim, RK | 1 |
Cho, EW | 1 |
Kim, IG | 1 |
Wei, YH | 1 |
Tang, HX | 1 |
Liao, YD | 1 |
Fu, SL | 1 |
Xu, LQ | 1 |
Chen, G | 1 |
Zhang, C | 1 |
Ju, S | 1 |
Liu, ZG | 1 |
You, LK | 1 |
Yu, L | 1 |
Zhou, S | 1 |
Zovko, A | 1 |
Novak, M | 1 |
Hååg, P | 1 |
Kovalerchick, D | 1 |
Holmlund, T | 1 |
Färnegårdh, K | 1 |
Ilan, M | 1 |
Carmeli, S | 1 |
Lewensohn, R | 2 |
Viktorsson, K | 1 |
Hurbin, A | 2 |
Dubrez, L | 2 |
Coll, JL | 2 |
Favrot, MC | 2 |
Cosaceanu, D | 1 |
Carapancea, M | 1 |
Alexandru, O | 1 |
Budiu, R | 1 |
Martinsson, HS | 1 |
Starborg, M | 1 |
Vrabete, M | 1 |
Kanter, L | 1 |
Dricu, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase 1 Study in Humans Evaluating the Safety of Rectus Sheath Implantation of Diffusion Chambers Encapsulating Autologous Malignant Glioma Cells Treated With Insulin-Like Growth Factor Receptor-1 Antisense Oligodeoxynucleotide in 12 Patients With Recurre[NCT01550523] | Phase 1 | 13 participants (Actual) | Interventional | 2012-02-09 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 other studies available for tyrphostin ag 1024 and Lung Neoplasms
Article | Year |
---|---|
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1.
Topics: A549 Cells; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Calcium-Binding Protei | 2018 |
Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer.
Topics: Adult; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Disease Models, Animal; Di | 2015 |
Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Erb | 2016 |
Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
Topics: Amphiregulin; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Culture Media, Condi | 2002 |
Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
Topics: Amphiregulin; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Culture Media, Serum-Free | 2003 |
Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Topics: Antibodies; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Humans; Lung | 2007 |